Evidence map›Paper›PMID 26322725›Full record

ReviewBiomaterials2015

In vivo bioresponses to silk proteins.

Amy E Thurber, Fiorenzo G Omenetto, David L Kaplan

Registry-linked trialAbstract readReview
In one paragraph

Review in Biomaterials, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03673449 (A Pilot Study to Evaluate the Reconstruction of Digital Nerve Defects in Humans Using an Implanted Silk Nerve Guide), which is not on this map. Cited by 146 papers.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed
16.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03673449 naunknown statusnot on this mapstarted 2019, after this paper: background citation

A Pilot Study to Evaluate the Reconstruction of Digital Nerve Defects in Humans Using an Implanted Silk Nerve Guide

TypeinterventionalSponsorSilk Biomaterials srlRan2019 to 2021Enrolled4ConditionsPeripheral Nerve Injury Digital Nerve HandArmsSilkBridge
3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 436 citations in OpenAlex.

  1. Application of Transgenic Silk Fibroin to Biomaterials.Biotechnology and bioengineering · 2026
    Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Recent Advances in Silk Fibroin Derived fromJournal of functional biomaterials · 2025
    Review
  10. Review
  11. Review
  12. Immunomodulatory Delivery Materials for Tissue Repair.Advanced healthcare materials · 2025
    Review
  13. Article
  14. Article
  15. Self-Assembly ofIndustrial & engineering chemistry research · 2025
    Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Exploring the functional properties ofMaterials today. Communications · 2025
    Article

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amy E ThurberDepartment of Biomedical Engineering, Tufts University, Medford, MA, 02155, USA; Program in Cell, Molecular, and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, MA, 02111, USA.
Fiorenzo G OmenettoDepartment of Biomedical Engineering, Tufts University, Medford, MA, 02155, USA.
David L KaplanDepartment of Biomedical Engineering, Tufts University, Medford, MA, 02155, USA. Electronic address: david.kaplan@tufts.edu.
Tufts University · US

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
Silica-protein Nanocomposites for Dental RepairR01DE017207 · NIDCR · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2007 to 2016
$3.0M
Tissue Engineering Cornea ReplacementsR01EY020856 · NEI · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2010 to 2016
$2.7M
Degradable orthopedic hardwareR01AR068048 · NIAMS · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L., LIN, SAMUEL J · 2015 to 2020
$2.0M
Multifunctional Tropoelastin-Silk Biomaterial SystemsR01EB014283 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2012 to 2015
$1.2M
NEI NIH HHS R01 EY020856NIAMS NIH HHS R01 AR068048NIBIB NIH HHS P41 EB002520NIBIB NIH HHS R01 EB014283NIDCR NIH HHS R01 DE017207
6 · The paper itself

Abstract

Silks are appealing materials for numerous biomedical applications involving drug delivery, tissue engineering, or implantable devices, because of their tunable mechanical properties and wide range of physical structures. In addition to the functionalities needed for specific clinical applications, a key factor necessary for clinical success for any implanted material is appropriate interactions with the body in vivo. This review summarizes our current understanding of the in vivo biological responses to silks, including degradation, the immune and inflammatory response, and tissue remodeling with particular attention to vascularization. While we focus in this review on silkworm silk fibroin protein due to the large quantity of in vivo data thanks to its widespread use in medical materials and consumer products, spider silk information is also included if available. Silk proteins are degraded in the body on a time course that is dependent on the method of silk fabrication and can range from hours to years. Silk protein typically induces a mild inflammatory response that decreases within a few weeks of implantation. The response involves recruitment and activation of macrophages and may include activation of a mild foreign body response with the formation of multinuclear giant cells, depending on the material format and location of implantation. The number of immune cells present decreases with time and granulation tissue, if formed, is replaced by endogenous, not fibrous, tissue. Importantly, silk materials have not been demonstrated to induce mineralization, except when used in calcified tissues. Due to its ability to be degraded, silk can be remodeled in the body allowing for vascularization and tissue ingrowth with eventual complete replacement by native tissue. The degree of remodeling, tissue ingrowth, or other specific cell behaviors can be modulated with addition of growth or other signaling factors. Silk can also be combined with numerous other materials including proteins, synthetic polymers, and ceramics to enhance its characteristics for a particular function. Overall, the diverse array of silk materials shows excellent bioresponses in vivo with low immunogenicity and the ability to be remodeled and replaced by native tissue making it suitable for numerous clinical applications.

Indexed as

Biocompatible MaterialsAnimalsBlood Vessel ProsthesisHumansProteinsSilkBiocompatible MaterialsProteinsSilkForeign body responseImmune responseInflammatory responseSilk fibroinTissue engineeringVascularization

Identifiers

PMID26322725
PMCPMC4573254
OpenAlexW1174494744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.